CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- 4 Grant or award Director acquired 34,403 shares (grant or award)
- 4 Grant or award Director acquired 34,403 shares (grant or award)
- 4 Grant or award Director acquired 34,403 shares (grant or award)
- 4 Grant or award Director acquired 34,403 shares (grant or award)
- 4 Grant or award Director acquired 34,403 shares (grant or award)
- 4 Grant or award Chairman acquired 34,403 shares (grant or award)
- 4 Grant or award Director acquired 34,403 shares (grant or award)
- 4 Grant or award Director acquired 34,403 shares (grant or award)
- 4 Shares withheld for taxes SVP, Bioservices gave up 561 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Quality & Ethics, and CPL gave up 480 shares (to pay taxes)
- 4/A Grant or award SVP, Bioservices acquired 62,500 shares (grant or award)
- 4 Open-market sale Director sold 35,000 shares at $5.83 ($204,050)
- 4 Open-market sale Director sold 10,000 shares at $5.73 ($57,300)
- 4 Derivatives Options or other derivatives
- 4 Grant or award SVP, General Counsel, Corp Sec acquired 62,500 shares (grant or award)
- 4 Grant or award SVP, Products Business acquired 62,500 shares (grant or award)
- 4 Grant or award EVP, Chief Financial Officer acquired 146,888 shares (grant or award)
- 4 Grant or award SVP, R&D, CMO acquired 62,500 shares (grant or award)
- 4 Grant or award SVP, Bioservices acquired 62,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 282,500 shares (grant or award)
Page 4 of 49 · 970 filings